NCT07380737Recruiting
Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 25 Jan 2026
- Start date
- 29 Dec 2025
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Diseases
- Parkinson disease
- NCT number
- NCT07380737
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 29 Dec 2025 to the primary completion date, 31 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in other concurrent intervention studies.
Other illness
- History of stroke, severe TBI, or brain tumor;
Other
- Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
- Cognitive impairments or severe behavioral symptoms;
- Cardiovascular contraindications;
- Inability to use a smartphone;
Who the study is looking for
- Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
- Hoehn \& Yahr stage II-III (ON-medication state);
- Able to walk independently for ≥5 minutes;
- Stable medication for ≥1 month;
- Currently enrolled in a rehab program at Ezra LeMarpe;
- Able to provide written informed consent;
Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tel Aviv Sourasky Medical Center (Ichilov Hospital) Coordinator of this site? Confirm its status | Tel Aviv | Israel | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.